ESPE Abstracts (2019) 92 P2-113

ESPE2019 Poster Category 2 Fat, Metabolism and Obesity (38 abstracts)

Prevalence and Correlation of Non Alcoholic Fatty Liver Disease (NAFLD) with Serum Alanine Aminotransferase (ALT) Levels in Obese Indian Children

Archana Arya , Hriday De & Vasundhara Chugh


Sir Ganga Ram Hospital, New Delhi, India


Aims: Non-alcoholic fatty liver disease (NAFLD) is the asymptomatic involvement of liver due to fatty infiltration of hepatocytes seen commonly in obese children. Elevated serum aminotransferase level serves as a surrogate marker of NAFLD. The recommended ALT cut-offs for screening for NAFLD in obese boys and girls are 22 and 25U/L respectively. We determined the prevalence of NAFLD amongst obese children in our population based on Liver Ultrasonography(USG), and determined the correlation of NAFLD with ALT levels and dyslipidemia in these children.

Methods: In this retrospective study, data from 223 obese children aged 1-18 years, with no other liver or chronic disease was analyzed. Body mass index, ALT, Fasting lipid profile, blood glucose and HbA1C were measured in all the subjects. NAFLD was diagnosed by ultrasonography. Presence of dyslipidemia was identified by any abnormality in the lipid profile as given below.

Abnormal, mg/dl
Total cholesterol≥200
LDL Cholesterol≥130
Triglycerides
<10y
10-19y

≥100
≥130
HDL Cholesterol<40

Abnormal values represent the 95th percentile, HDL cholesterol represents the 10th percentile.

Result: We found a very high prevalence of NAFLD (40.8%) in our obese population based on USG. 71.4% children with NAFLD had associated dyslipidemia. We also found a very high prevalence of NAFLD in the group with ALT<22 in girls (33%) and ALT<25 in boys (25%).

Percentage of children with NAFLD in relation to ALT levels and it's correlation with dyslipidemia.

Girls

ALT (U/L)≤22>22-40> 40Overall
NAFLD (USG)33.33% (15/45)34.14% (14/41)55.5% (20/36)40.16% (49/122)
Dyslipidemia73.33% (11/15)42.85% (6/14)85% (17/20)69.3% (34/49)

Boys

ALT U/L≤25>25-40>40Overall
NAFLD (USG)25% (10/40)22.2% (6/27)76.47% (26/34)41.5% (42/101)
Dyslipidemia70%(7/10)33.3% (2/6)84.61% (22/26)73.8%(31/42 )

Conclusion: The prevalence of NAFLD in obese children based on Liver USG in our population was very high (40.8%). Although USG may not be a very reliable way of diagnosing NAFLD, it is a warning to monitor for progression of liver disease in these children. We also found that 25/85 (29.4%) girls and boys with ALT levels below the recommended cut-offs of <22 and 25U/L respectively had NAFLD. This is a fairly large number of children in whom liver disease may be missed out if we follow the recommended ALT cut-offs. Hence we recommend that in our population all obese children should be screened for NAFLD by USG irrespective of the ALT levels.

Volume 92

58th Annual ESPE (ESPE 2019)

Vienna, Austria
19 Sep 2019 - 21 Sep 2019

European Society for Paediatric Endocrinology 

Browse other volumes

Article tools

My recent searches

No recent searches.